Substance Abuse Treatment Market Research Report Information By Type (Alcohol Dependence and Tobacco & Drug Abuse), By End User (Outpatient Treatment Centers, Residential Treatment Centers, and Inpatient Treatment Centers), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Macroeconomic Indicators

4.5 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Substance Abuse Treatment Market, by Abuse Type

6.1 Introduction

6.2 Alcohol Dependence

6.3 Tobacco/Nicotine Addiction

6.4 Drug Abuse

6.5 Others

Chapter 7. Global Substance Abuse Treatment Market, by Treatment Type

7.1 Introduction

7.2 Alcohol Addiction Treatment

7.2.1 Disulfiram

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.2.2 Acamprosate

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.2.3 Naltrexone

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.3 Tobacco/Nicotine Addiction Treatment

7.3.1 Nicotine Replacement Treatment

7.3.1.1 Nicotine Patch

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.3.1.2 Nicotine Gum

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.3.1.3 Nicotine Lozenge

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.3.1.4 Nicotine Spray

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.3.1.5 Nicotine Inhaler

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.3.2 Non-Nicotine Medication

7.3.2.1 Bupropion

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.3.2.2 Varenicline

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.4 Drug Abuse Treatment

7.4.2.1 Methadone

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.4.2.2 Buprenorphine

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.4.2.3 Naltrexone

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

Chapter 8. Global Substance Abuse Treatment Market, by End User

8.1 Introduction

8.2 Outpatient Treatment Centers

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.3 Residential Treatment Centers

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.4 Inpatient Treatment Centers

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

Chapter 9. Global Substance Abuse Treatment Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Pfizer Inc.

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Alkermes Plc

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 GlaxoSmithKline Plc.

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Purdue Pharma LP

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Allergan

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Mylan Laboratories

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Reckitt Benckiser Pharmaceuticals,

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Teva Pharmaceuticals

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Forest Laboratories, Inc.

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Accord Healthcare

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Amphastar Pharmaceuticals

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Apotex

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 BioCorRx

11.13.1 Overview

11.13.2 Product Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 Cipla

11.14.1 Overview

11.14.2 Product Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

11.15 Sun Pharmaceuticals

11.15.1 Overview

11.15.2 Product Overview

11.15.3 Financials

11.15.4 Key Developments

11.15.5 SWOT Analysis

11.16 Other

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictionsfor the global substance abuse treatment market

Chapter 13. Appendix

LIST OF TABLES

Table 1 Substance Abuse Treatment Market Synopsis, 2023-2030

Table 2 Substance Abuse Treatment Market Estimates and Forecast, 2023-2030 (USD Million)

Table 3 Global Substance Abuse Treatment Market, by Region, 2023-2030 (USD Million)

Table 4 Global Substance Abuse Treatment Market, by Abuse Type, 2023-2030 (USD Million)

Table 5 Global Substance Abuse Treatment Market, by Treatment Type, 2023-2030 (USD Million)

Table 6 Global Substance Abuse Treatment Market, End User, 2023-2030 (USD Million)

Table 7 North America: Substance Abuse Treatment Market, by Abuse Type, 2023-2030 (USD Million)

Table 8 North America: Substance Abuse Treatment Market, by Treatment Type, 2023-2030(USD Million)

Table 9 North America: Substance Abuse Treatment Market, End User, 2023-2030 (USDMillion)

Table 10 US: Substance Abuse Treatment Market, by Abuse Type, 2023-2030 (USD Million)

Table 11 US: Substance Abuse Treatment Market, by Treatment Type, 2023-2030 (USD Million)

Table 12 US: Substance Abuse Treatment Market, End User, 2023-2030 (USD Million)

Table 13 Canada:Substance Abuse Treatment Market,byAbuse Type, 2023-2030 (USD Million)

Table 14 Canada: Substance Abuse Treatment Market, by Treatment Type, 2023-2030 (USD Million)

Table 15 Canada: Substance Abuse Treatment Market, End User, 2023-2030 (USDMillion)

Table 16 South America: Substance Abuse Treatment Market, by Abuse Type, 2023-2030 (USD Million)

Table 17 South America: Substance Abuse Treatment Market, by Treatment Type, 2023-2030 (USD Million)

Table 18 South America: Substance Abuse Treatment Market, End User, 2023-2030 (USDMillion)

Table 19 Europe: Substance Abuse Treatment Market, by Abuse Type, 2023-2030 (USD Million)

Table 20 Europe: Substance Abuse Treatment Market, by Treatment Type, 2023-2030 (USD Million)

Table 21 Europe: Substance Abuse Treatment Market, End User, 2023-2030 (USD Million)

Table 22 Western Europe: Substance Abuse Treatment Market, by Abuse Type, 2023-2030 (USDMillion)

Table 23 Western Europe: Substance Abuse Treatment Market, by Treatment Type, 2023-2030 (USD Million)

Table 24 Western Europe: Substance Abuse Treatment Market, by End User, 2023-2030(USD Million)

Table 25 Eastern Europe: Substance Abuse Treatment Market, by Abuse Type, 2023-2030 (USD Million)

Table 26 Eastern Europe: Substance Abuse Treatment Market, by Treatment Type, 2023-2030 (USD Million)

Table 27 Eastern Europe: Substance Abuse Treatment Market, End User, 2023-2030(USD Million)

Table 28 Asia-Pacific: Substance Abuse Treatment Market, by Abuse Type, 2023-2030 (USD Million)

Table 29 Asia-Pacific: Substance Abuse Treatment Market,by Treatment Type, 2023-2030 (USD Million)

Table 30 Asia-Pacific: Substance Abuse Treatment Market, End User, 2023-2030 (USD Million)

Table 31 Middle East & Africa: Substance Abuse Treatment Market, by Abuse Type, 2023-2030 (USD Million)

Table 32 Middle East & Africa: Substance Abuse Treatment Market, by Treatment Type,2023-2030 (USD Million)

Table 33 Middle East & Africa: Substance Abuse Treatment Market, End User, 2023-2030(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Substance Abuse Treatment Market

Figure 3 Market Dynamics for Global Substance Abuse Treatment Market

Figure 4 Substance Abuse Treatment Market Share, by Abuse Type,2023

Figure 5 Substance Abuse Treatment Market Share, by Treatment Type,2023

Figure 6 Substance Abuse Treatment Market Share, End User, 2023

Figure 7 Substance Abuse Treatment Market Share, by Region, 2023

Figure 8 North America: Substance Abuse Treatment Market Share, by Country, 2023

Figure 9 Europe: Substance Abuse Treatment Market Share, by Country, 2023

Figure 10 Asia-Pacific: Substance Abuse Treatment Market Share, by Country, 2023

Figure 11 Middle East & Africa: Substance Abuse Treatment Market Share, by Region, 2023

Figure 12 Substance Abuse Treatment Market : Company Share Analysis, 2023 (%)

Figure 13 Pfizer Inc.: Key Financials

Figure 14 Pfizer Inc.: Segmental Revenue

Figure 15 Pfizer Inc.: Geographical Revenue

Figure 16 Alkermes Plc : Key Financials

Figure 17 Alkermes Plc : Segmental Revenue

Figure 18 Alkermes Plc : Geographical Revenue

Figure 19 GlaxoSmithKline Plc.:Key Financials

Figure 20 GlaxoSmithKline Plc.: Segmental Revenue

Figure 21 GlaxoSmithKline Plc.: Geographical Revenue

Figure 22 Purdue Pharma LP: Key Financials

Figure 23 Purdue Pharma LP: Segmental Revenue

Figure 24 Purdue Pharma LP: Geographical Revenue

Figure 25 Allergan:Key Financials

Figure 26 Allergan: Segmental Revenue

Figure 27 Allergan: Geographical Revenue

Figure 28 Mylan Laboratories: Key Financials

Figure 29 Mylan Laboratories: Segmental Revenue

Figure 30 Mylan Laboratories: Geographical Revenue

Figure 31 Reckitt Benckiser Pharmaceuticals, : Key Financials

Figure 32 Reckitt Benckiser Pharmaceuticals, : Segmental Revenue

Figure 33 Reckitt Benckiser Pharmaceuticals, : Geographical Revenue

Figure 34 Teva Pharmaceuticals:Key Financials

Figure 35 Teva Pharmaceuticals: Segmental Revenue

Figure 36 Teva Pharmaceuticals: Geographical Revenue

Figure 37 Forest Laboratories, Inc.: Key Financials

Figure 38 Forest Laboratories, Inc.: Segmental Revenue

Figure 39 Forest Laboratories, Inc.: Geographical Revenue

Figure 40 Accord Healthcare: Key Financials

Figure 41 Accord Healthcare: Segmental Revenue

Figure 42 Accord Healthcare: Geographical Revenue

Figure 43 Amphastar Pharmaceuticals : Key Financials

Figure 44 Amphastar Pharmaceuticals :Segmental Revenue

Figure 45 Amphastar Pharmaceuticals : Geographical Revenue

Figure 46 Apotex: Key Financials

Figure 47 Apotex: Segmental Revenue

Figure 48 Apotex: Geographical Revenue

Figure 49 BioCorRx: Key Financials

Figure 50 BioCorRx: Segmental Revenue

Figure 51 BioCorRx: Geographical Revenue

Figure 52 Cipla: Key Financials

Figure 53 Cipla: Segmental Revenue

Figure 54 Cipla: Geographical Revenue

Figure 55 Sun Pharmaceuticals: Key Financials

Figure 56 Sun Pharmaceuticals: Segmental Revenue

Figure 57 Sun Pharmaceuticals: Geographical Revenue